BRIEF-Biocept, Catalyst Pharma to provide liquid biopsy testing for small cell lung cancer
March 14, 2017 at 08:18 AM EDT
* Biocept and Catalyst Pharmaceuticals collaborate to provide liquid biopsy testing for small cell lung cancer to patients with Lambert Eaton Myasthenic Syndrome (LEMS)
